Foundation Medicine, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$4.59B

679 transactions

Summary

Foundation Medicine, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $3.00BSales: $549.5M33 insiders

Date	Insider	Type	Value
2018-07-31	Joint reporting: ROCHE HOLDING LTD; ROCHE HOLDINGS INC; ROCHE FINANCE LTD	Buy	$1.90B
2018-07-31	Joint reporting: ROCHE HOLDING LTD; ROCHE HOLDINGS INC; ROCHE FINANCE LTD	Buy	$321.0M
2018-07-31	Cox Troy(President and CEO)	J	$28.3M
2018-07-31	Hesslein Robert W.(SVP and General Counsel)	U	$10.5M
2018-07-31	Borisy Alexis	U	$10.0M
2018-07-31	Doherty Michael J(Head of Product Development)	J	$9.0M
2018-07-31	Cox Troy(President and CEO)	U	$4.8M
2018-07-31	Civik Thomas(Chief Commercial Officer)	J	$4.6M
2018-07-31	Hesslein Robert W.(SVP and General Counsel)	J	$3.9M
2018-07-31	Fiedler Konstantin(Chief Operating Officer)	J	$3.2M
2018-07-31	JONES EVAN/ FA	U	$2.4M
2018-07-31	Doherty Michael J(Head of Product Development)	U	$2.2M
2018-07-31	DOUGHERTY MICHAEL R	J	$1.7M
2018-07-31	DOUGHERTY MICHAEL R	U	$1.7M
2018-07-31	JONES EVAN/ FA	U	$1.3M
2018-07-31	Fiedler Konstantin(Chief Operating Officer)	U	$446K
2018-07-31	Borisy Alexis	H	$0
2018-07-31	JONES EVAN/ FA	H	$0
2018-07-31	JONES EVAN/ FA	H	$0
2018-07-31	JONES EVAN/ FA	H	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Foundation Medicine, Inc. — Contributions, Lobbying & Contracts | Poliscope